CLINICAL_TRIALS
trial_result
· 2019-04-16
Clinical Trial Update: Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 clinical trial update evaluating adjuvant gefitinib (Iressa) for resectable hepatocellular carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tan Tock Seng Hospital | Conditions: Liver Cancer | Phase 2 | Status: UNKNOWN